Gilde Healthcare β 2020 Investments
3 investments dated 2020 Β· listed companies and verified rows first Β· show all
Eagle Pharmaceuticals develops and commercializes specialty pharmaceutical products for acute care and oncology, including injectable medications for procedural sedation, chemotherapy, lymphomas, and malignant hyperthermia management.
BiotechHealthtechMedical DevicesIndianapolis, US
Co-investorsF-Prime Capital
LAVA develops the Gammabody platform, which generates bispecific antibodies that activate gamma-delta T cells to treat cancer by directing immune cells to tumors and triggering anti-cancer immune responses.
AI & Machine LearningBiotechHealthtechMedical Devices
Ton AdanginHans van der Vliet(Head of Innovation)inSteve Hurly(Chief Executive Officer)Oxana Polyakova(Chief Scientific Officer)in
Co-investorsMRL Ventures FundSanofi VenturesYsios CapitalREDMILE
Vapotherm manufactures high-velocity therapy devices for respiratory distress treatment across patient populations.
HardwareHealthtechMedical DevicesExeter, US
JOSEPH ARMY(Executive Officer, Director)JOHN LANDRY(Executive Officer)in
BoardANTHONY ARNERICH(Director)JASON LETTMAN(Director)GEOFF PARDO(Director)inSAMUEL BRASCH(Director)
Co-investorsCross Creek AdvisorsKaiser Permanente VenturesQuestMark Partners3x5 Partners
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.